Loading...
Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
Pancreatic cancer is a highly lethal malignancy which tends to present with late stage disease. To date, identification of oncogenic drivers and aberrations has not led to effective targeted therapy. Approximately 5–15% of pancreatic cancer has an inheritable component. In fact, pancreatic adenocarc...
Saved in:
| Published in: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056255/ https://ncbi.nlm.nih.gov/pubmed/27747088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.05.04 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|